Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pratesi

Showing results (11-20 of 163) with videos related to

Pageof 17
Sort By:
Biochemical Pharmacology|February 28, 2001
Role of Bcl-2 and its post-transcriptional modification in response to antitumor therapyG Pratesi, P Perego, F Zunino
Biochemical Pharmacology|April 5, 2001
Role of the sugar moiety in the pharmacological activity of anthracyclines: development of a novel series of disaccharide analogsF Zunino, G Pratesi, P Perego
Anti-Cancer Drugs|October 1, 1990
Different interaction of cisplatin and etoposide on in vivo and in vitro tumor systemsC Soranzo, G Pratesi, F Zunino
The International Journal of Artificial Organs|October 1, 1994
Electrolyte-bicarbonate reinfusate in a two chambers bag in HDFM Gonella, G Calabrese, G Pratesi
Tumori|June 30, 1991
The exponential-Gompertzian tumor growth model: data from six tumor cell lines in vitro and in vivo. Estimate of the transition point from exponential to Gompertzian growth and potential clinical implicationsR Demicheli, G Pratesi, R Foroni
Annals of the New York Academy of Sciences|February 24, 2001
Improvement of therapeutic index of low-dose topotecan delivered per osG Pratesi, M De Cesare, F Zunino
Clinical & Experimental Metastasis|January 1, 1993
Importance of orthotopic implantation for human tumors as model systems: relevance to metastasis and invasionC Manzotti, R A Audisio, G Pratesi
Cancer Chemotherapy and Pharmacology|January 1, 1996
Efficacy of lonidamine combined with different DNA-damaging agents in the treatment of the MX-1 tumor xenograftG Pratesi, M De Cesare, F Zunino
Clinical Nephrology|November 1, 1984
Non A-non B hepatitis in a dialysis population: spread by dental surgery?G Vagelli, G Calabrese, G Pratesi, et al.
Farmaco (Societa Chimica Italiana : 1989)|September 1, 1992
Current approaches to new drug development in cancer chemotherapyF Zunino, G Capranico, G Pratesi, et al.
Pageof 17

Showing results (11-20 of 163) with videos related to

Sort By:
Pageof 17
Biochemical Pharmacology|February 28, 2001
Role of Bcl-2 and its post-transcriptional modification in response to antitumor therapyG Pratesi, P Perego, F Zunino
Biochemical Pharmacology|April 5, 2001
Role of the sugar moiety in the pharmacological activity of anthracyclines: development of a novel series of disaccharide analogsF Zunino, G Pratesi, P Perego
Anti-Cancer Drugs|October 1, 1990
Different interaction of cisplatin and etoposide on in vivo and in vitro tumor systemsC Soranzo, G Pratesi, F Zunino
The International Journal of Artificial Organs|October 1, 1994
Electrolyte-bicarbonate reinfusate in a two chambers bag in HDFM Gonella, G Calabrese, G Pratesi
Tumori|June 30, 1991
The exponential-Gompertzian tumor growth model: data from six tumor cell lines in vitro and in vivo. Estimate of the transition point from exponential to Gompertzian growth and potential clinical implicationsR Demicheli, G Pratesi, R Foroni
Annals of the New York Academy of Sciences|February 24, 2001
Improvement of therapeutic index of low-dose topotecan delivered per osG Pratesi, M De Cesare, F Zunino
Clinical & Experimental Metastasis|January 1, 1993
Importance of orthotopic implantation for human tumors as model systems: relevance to metastasis and invasionC Manzotti, R A Audisio, G Pratesi
Cancer Chemotherapy and Pharmacology|January 1, 1996
Efficacy of lonidamine combined with different DNA-damaging agents in the treatment of the MX-1 tumor xenograftG Pratesi, M De Cesare, F Zunino
Clinical Nephrology|November 1, 1984
Non A-non B hepatitis in a dialysis population: spread by dental surgery?G Vagelli, G Calabrese, G Pratesi, et al.
Farmaco (Societa Chimica Italiana : 1989)|September 1, 1992
Current approaches to new drug development in cancer chemotherapyF Zunino, G Capranico, G Pratesi, et al.
Pageof 17